findmyKOL

Anjali Vaidya, MD

Basic profile

Temple University Health System

ORCIDNPI
RegionPhiladelphia, PA · NortheastSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Anjali Vaidya is a Cardiology physician affiliated with Temple University Health System. OpenAlex indexes 150 publications with 2,123 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
150publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,123citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
72companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

72 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

72 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60.8%
    Endothelin Receptor Antagonist26.7%
    Opsumit87%Ambrisentan13%
    Part D<11 patients
    Soluble Guanylate Cyclase Stimulator18.8%
    Adempas100%
    Part D28 patients

    + 5 more classes in this area

  • Genitourinary & hormones

    20.4%
    Phosphodiesterase 5 Inhibitor20.4%
    Sildenafil Citrate58%Tadalafil34%Adcirca8%
    Part D<11 patients
  • Blood & clotting

    13.9%
    Prostacycline Vasodilator8.5%
    Orenitram Er55%Tyvaso Dpi45%
    Part D<11 patients
    Prostacyclin Receptor Agonist3.3%
    Uptravi100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”